PRISMAP's Workshop and Consortium Meeting 8 was hosted by SCK CEN at Sunparks Kempense Meren, Mol, Belgium

Workshop on Emerging Infrastructures

The Workshop gave a general introduction to infrastructures producing radionuclides, which were subject to a large study developed by the PRISMAP partners to explore and optimize production of key isotopes for the user community. The assessments of the PRISMAP labs were presented and discussed. The last session of the workshop was dedicated to the realization of a White Paper, presenting the infrastructures, the results and conclusions of the study.

To ensure sustainability and a good geographical coverage, emerging infrastructures received special attention in PRISMAP. The organization of this workshop was one of the activities in support of the emerging facilities. The aim was to explore and develop their radionuclide-production capacity, to discuss radionuclides of interest to the user community and current/future R&D efforts towards the realization of new infrastructures and improved performances. The programme included sessions on the following topics:

• Emerging Infrastructures - assessment for specific radionuclides
• Mass separation for isotopic enrichment
• Technical developments for radionuclide production
• Round-table discussion on innovative radionuclides and user needs

Consortium Meeting 8 (CM8)

CM8 combined internal reporting and strategy sessions and public engagement:

“PRISMAP Meets Industries” event where Industry guests shared insights on radiopharmaceutical development, logistics, and the path to clinical application

Bringing together leading voices from across the radiopharmaceutical value chain, the event offered an interesting dive into the opportunities and challenges shaping the future of NuclearMedicine in Europe for the benefit of patients. From cutting-edge alpha theranostics to industrial-scale isotope production and logistics, our speakers highlighted the power of collaboration between research, industry and healthcare to accelerate innovation in cancer care.

Highlights included: Thierry Stora (CERN) – setting the scene with PRISMAP’s mission; Bernard Ponsard (SCKCEN) – giving NuclearMedicineEurope (NMEU)’s perspective; Anne Royer Moës Moes (IBA) – on alpha theranostics and the AccelerateEU project; Grégory Saive (TRASIS) – accelerating adoption of radiopharmaceuticals; Samy Bertrand (PANTERA) – on Ac-225 production at scale; Raphaël (Raph) ORTIZ (Telix EMEA) – navigating theranostic opportunities; Jean-Michel Luyckx - the Belgian perspective; D'Huyvetter, Matthias (PRECIRIX) – bridging R&D and industrial translation; Frank Vanderlinden (SCKCEN) – enabling secure PRISMAP transports; Claude Poliart (Life Couriers) – insights on medical isotope logistics.

Grateful to all the speakers, moderators, and participants for their openness and inspiring contributions. A big thank you to the PRISMAP community for facilitating these important exchanges and to SCKCEN (and in particular Lucia Popescu) for hosting and organizing the event.

• Public Event: PRISMAP users presented their research, including theranostic tools, targeted therapies, and imaging.
• Internal Discussions: The consortium reviewed project progress, discussed sustainability, and prepared for the final phase of the project.

The meeting concluded with a General Assembly presenting and discussing the roadmap toward Consortium Meeting 9.

Meeting atmosphere and discussions at CM8

Discussing project news and PRISMAP meets industry event

The goal of the Consortium Meeting (CM8) was to prepare the last months of the project. Our public event, which has already become a tradition at our consortium meetings, rounded off the meeting with our project news and exciting reports from our user projects. Many, many thanks to SCK-CEN, our host, especially Lucia Anna Popescu and her team, for a beautiful experience in the Lake District near Mol/Belgium!